Bayban’s Eli Lilly LLY Stock Holding History

Bayban’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Sell	121 -37	-23%	-$37.8K	0.11%	132
2026 Q1	$145K	Hold	158	–	–	0.13%	130
2025 Q4	$170K	Buy	+158	New	+$151K	0.15%	108

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bayban's LLY Position: Q2 2026 in Review

Bayban reduced its Eli Lilly (LLY) stake by 23% in Q2 2026, selling an estimated $37.8K and leaving 121 shares worth $145K. The position accounts for 0.11% of the portfolio, ranked #132.

Bayban first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $170K in Q4 2025. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Bayban held 121 shares of Eli Lilly worth $145K as of Q2 2026.
Bayban sold 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
Eli Lilly made up 0.11% of Bayban's portfolio in Q2 2026, its #132 holding.
Bayban first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
Bayban's Eli Lilly position peaked at $170K in Q4 2025.
4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.